Cargando…

Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis

Objective: Metabolic reprogramming is an important biomarker of cancer. Metabolic adaptation driven by oncogenes allows tumor cells to survive and grow in a complex tumor microenvironment. The heterogeneity of tumor metabolism is related to survival time, somatic cell-driven gene mutations, and tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guangwei, Liu, Xiaofei, Wang, Dandan, Sun, Meige, Yang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025671/ https://www.ncbi.nlm.nih.gov/pubmed/33842342 http://dx.doi.org/10.3389/fonc.2021.636565

Ejemplares similares

Identification of Four Metabolic Subtypes of Glioma Based on Glycolysis-Cholesterol Synthesis Genes
por: Zhang, Jinsen, et al.
Publicado: (2022)

Classification and Prognostic Characteristics of Hepatocellular Carcinoma Based on Glycolysis Cholesterol Synthesis Axis
por: Deng, Weijie, et al.
Publicado: (2022)

Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer
por: Chen, Yan-Jie, et al.
Publicado: (2022)

Aberrant gene expression pattern in the glycolysis-cholesterol synthesis axis is linked with immune infiltration and prognosis in prostate cancer: A bioinformatics analysis
por: Yuan, Yiwen, et al.
Publicado: (2022)

Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model
por: Zhang, Enchong, et al.
Publicado: (2021)

Research progress of LINE-1 in the diagnosis, prognosis, and treatment of gynecologic tumors
por: Fu, Jiaojiao, et al.
Publicado: (2023)

The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis
por: Liu, Hao, et al.
Publicado: (2021)

Thrombospondin 2/Toll-Like Receptor 4 Axis Contributes to HIF-1α-Derived Glycolysis in Colorectal Cancer
por: Xu, Chunjie, et al.
Publicado: (2020)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma
por: Qiu, Lin, et al.
Publicado: (2022)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

Association Between Metformin Use and the Risk, Prognosis of Gynecologic Cancer
por: Yao, Kui, et al.
Publicado: (2022)

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis
por: Zhang, Rixin, et al.
Publicado: (2020)

Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis
por: Shen, Yu-ting, et al.
Publicado: (2021)

Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis
por: Zhao, Yue, et al.
Publicado: (2016)

Mu opioid receptor mRNA overexpression predicts poor prognosis among 18 common solid cancers: A pan-cancer analysis
por: Sun, Wei, et al.
Publicado: (2023)

Superficial vaginal myofibroblastoma with mushroom-like appearance: A case report with colposcopic findings and literature review
por: Wang, Yibei, et al.
Publicado: (2022)

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment
por: He, Songjiang, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
por: Wang, Shunda, et al.
Publicado: (2020)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma
por: Xu, Fangxing, et al.
Publicado: (2022)

MiR-365a-3p-Mediated Regulation of HELLS/GLUT1 Axis Suppresses Aerobic Glycolysis and Gastric Cancer Growth
por: Yang, Rui, et al.
Publicado: (2021)

DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
por: Yuan, Ziming, et al.
Publicado: (2023)

Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors
por: Zhang, Yajing, et al.
Publicado: (2022)

The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis
por: Simoni-Nieves, Arturo, et al.
Publicado: (2021)

Common Multiple Primary Cancers Associated With Breast and Gynecologic Cancers and Their Risk Factors, Pathogenesis, Treatment and Prognosis: A Review
por: Ge, Shuwen, et al.
Publicado: (2022)

Prognostic value analysis of cholesterol and cholesterol homeostasis related genes in breast cancer by Mendelian randomization and multi-omics machine learning
por: Wu, Haodong, et al.
Publicado: (2023)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
por: Lu, Lingling, et al.
Publicado: (2022)

Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer
por: Yu, Shanshan, et al.
Publicado: (2020)

A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer
por: Guo, Kaixuan, et al.
Publicado: (2021)

Comprehensive analysis of aerobic glycolysis-related genes for prognosis, immune features and drug treatment strategy in prostate cancer
por: He, Wei, et al.
Publicado: (2022)

Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer
por: Gao, Bo, et al.
Publicado: (2021)

Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma
por: Mi, Jinglin, et al.
Publicado: (2022)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

TOP2A correlates with poor prognosis and affects radioresistance of medulloblastoma
por: Zhang, Yufeng, et al.
Publicado: (2022)

CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rldmli70mm176voaajpisppn79